Based on transcriptomic data analyzed in this work, CLDN6 expression is expected in several samples of rare subtypes of acute myeloid leukemia (AML), namely acute megakaryoblastic leukemia and core-binding factor AML. This evidence concerns the gene CLDN6 and acute myeloid leukemia.